Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist

Gahlaut, R, Bennett, A, Fatayer, H et al. (7 more authors) (2016) Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression - Implications for the practising oncologist. European journal of cancer, 60. pp. 40-48. ISSN 0959-8049

Abstract

Metadata

Authors/Creators:
Keywords: Neoadjuvant chemotherapy; Breast cancer; Oestrogen receptor; Progesterone receptor; HER2
Dates:
  • Accepted: 9 March 2016
  • Published (online): 8 April 2016
  • Published: June 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Oct 2016 12:05
Last Modified: 04 Nov 2016 07:01
Published Version: http://dx.doi.org/10.1016/j.ejca.2016.03.006
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ejca.2016.03.006
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics